The letter below was written by Mr. Stephen Flatow, esteemed secretary and treasurer of the Board of Trustees of the American Friends of Rabin Medical Center, in response to a New York Times article alleging that Palestinians were leaving Israeli hospitals and seeking healthcare elsewhere. The original New York Times article can be found here.
February 14, 2009 Letter Palestinians' Health Care To the Editor: Re "Palestinians Stop Paying Israeli Hospitals for Gaza and West Bank Patients" (news article, Feb. 10): The Palestinian Authority's decision to force the removal of Palestinian patients from Israeli hospitals is a sad one. Israel's major hospital centers — among them, Rabin Medical Center, Hadassah Hospital and Soroka Medical Center — are on a par with the finest institutions in the United States and provide a quality of care and treatment not found in the West Bank, Egypt or Jordan. They are leaders in robotic surgery, cancer research and treatment, organ transplantation, stem cell research and therapies, and have become world renowned for trauma care. How is it in the interest of Palestinians to be treated as medically second-class patients by depriving them of the best treatment? If there is to be coexistence between Palestinians and Israelis, what better way to work toward that goal than through the trust created by the bond between doctor, nurse and patient? Given the chance to break down stereotypes held by Palestinians and Israelis about each other, why lose that opportunity? Stephen M. Flatow
West Orange, N.J., Feb. 10, 2009
The Sixth Annual Cheryl Diamond NYC 5k Schlep Run / Walk in Battery Park on June 5, 2016 highlighted the BRCA Gene Multidisciplinary Clinic, serving women at high risk of breast and ovarian cancer.
Former Ohio Senator Howard Metzenbaum,
founding Honorary Chairman of the American
Friends of Rabin Medical Center (AFRMC), died at the age of 90 in March.
For the first time in Israel, at Rabin Medical Center Stereotactic Body Radiation (SBRT) treatment is available for certain lung cancer patients using the Trilogy Linear Accelerator, the most advanced accelerator available today.